Stock data
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS) reported revenue of US$16.80M and net income of -US$43.32M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$16.80M | — | -US$32.43M | -US$43.32M | — |
| 2024 | US$0.00M | — | -US$7.57M | -US$7.96M | — |
| 2023 | — | — | -US$6.86M | -US$7.38M | — |
| 2022 | — | — | -US$2.32M | -US$2.46M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$15.60M | -US$23.42M | — |
| 2026-03-31 | US$10.91M | -US$25.07M | — |
| 2025-12-31 | US$16.50M | -US$21.66M | — |
| 2025-09-30 | US$0.29M | -US$16.24M | — |
| 2025-06-30 | US$0.00M | -US$3.45M | — |
| 2025-03-31 | US$0.00M | -US$1.97M | — |
| 2024-12-31 | — | -US$1.93M | — |
| 2024-09-30 | — | -US$1.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.